Knowing a fact, and checking it
The official PSA site says candidates can refer to the online BNF at any point during the assessment, and also that the BNF does not answer every prescribing question. Some marks rest on judgement and on the data in the question. Many, though, depend on a specific number or instruction that recall gets roughly right and the BNF gets exactly right:
| What you might remember | What the BNF lets you state |
|---|---|
| Metformin and poor kidney function do not mix | Avoid in adults if eGFR is below 30 mL/minute/1.73 m² (Renal impairment) |
| Dabigatran is renally cleared | Avoid if creatinine clearance is below 30 mL/minute (Renal impairment) |
| Diet affects warfarin | Vitamin K in food, supplements and enteral feeds can reduce its effect; major changes in diet or alcohol affect control (interactions page, Food and lifestyle) |
Where answers live
Most PSA lookups start in one of four places. Choosing the right one first is the biggest time saving.
Illustrative schematic, not the live BNF
What is the question asking?
Which drug for this condition?
Treatment summaries
The choice of drug by condition, severity and patient group, with steps and alternatives. Then open the chosen drug's monograph for the dose.
Hypertension (BNF, opens in a new tab) · Respiratory system infections (BNF, opens in a new tab)
Dose, safety, monitoring or advice for a named drug
Drug monographs
One page per drug: dose by indication, contra-indications, side-effects, special patient groups, monitoring, administration and medicinal forms.
Do these two drugs interact?
Interactions
A separate page per drug, listing every interacting drug alphabetically with the effect, the advice, a severity and the evidence behind it.
A general prescribing principle
Medicines guidance
How to approach renal and hepatic impairment, pregnancy, breast-feeding, children and older people, plus prescription writing and controlled drugs.
Prescribing in renal impairment (BNF, opens in a new tab) · All medicines guidance (BNF, opens in a new tab)
Inside a drug monograph
A monograph is long, but its headings come in a consistent order and fall into a few groups. Learn the groups and you can predict where an answer is before you scroll.
Illustrative schematic, not the live BNF
What it is for, and how much
- Indications and dose2the dose under each indication, then by route, then by age band
- Unlicensed useuses outside the licence that the BNF still covers
Is it safe for this patient?
- Important safety informationMHRA and CHM warnings, in an outlined box
- Contra-indications3when not to use it
- Cautionswhen to use it with care
- Interactions4a link to the drug's separate interactions page
- Side-effects3grouped by frequency band
- Allergy and cross-sensitivityfor drugs where it matters
Special patient groups
- Conception and contraceptionwhere a drug needs it
- Pregnancy
- Breast feeding
- Hepatic impairment
- Renal impairment5avoidance and dose bands, stated in CrCl or eGFR
Before and during treatment
- Pre-treatment screeningtests before the first dose
- Monitoring requirementswhat to check, when, and target levels
- Effect on laboratory tests
- Treatment cessationhow to stop
Giving it and explaining it
- Directions for administrationhow and when to take or give it
- Prescribing and dispensing information
- Patient and carer advicecounselling points
The products
- Medicinal formsformulations, strengths and cautionary labels
- Headings appear only when there is something to say. Amiodarone's monograph has no Renal impairment heading at all. A missing heading means the BNF has no specific entry there, not that the drug is safe in that situation: use the Medicines guidance page and the product literature.
- Doses are nested. Indication first, then route, then age band (Adult, Child 12–17 years and so on). The right number sits under the indication in the question; other indications often carry a different regimen.
- Class text is labelled. Lines headed “For all beta-adrenoceptor blockers (systemic)” apply to every drug in that class; lines headed with the drug's own name apply to that drug. Read both.
- Interactions is a link, not a list. The heading in the monograph only says “View interactions for…”. The advice is on the interactions page.
- Renal advice states its own measure. Each drug's entry gives its thresholds in creatinine clearance (mL/minute) or in eGFR (mL/minute/1.73 m²), and may have a Dose adjustments sub-heading. See the renal section below.
The lookup, step by step
- Name what you needDose, interaction, side-effect, monitoring, counselling, or a choice of drug. A choice of drug needs a treatment summary, not a monograph.
- Search the right nameThe generic drug name, or the condition when you need a choice. Combination products such as co-amoxiclav have their own monograph, but the interactions pages do not list combinations: check each constituent (amiloride and furosemide for co-amilofruse).
- Jump to the headingUse the section links at the top of the monograph, or Ctrl+F (Cmd+F on a Mac) for a word such as renal, monitoring or oedema.
- Read the entry for this patientFor a dose: the indication, route and age band. For renal advice: the band and the measure it uses. Read the class text (“For all…”) as well as the drug's own.
- Return to the questionAnswer in the question's terms. If a lookup is not converging after a minute or so, flag the item and come back to it.
Renal impairment: which number to use
Laboratories report eGFR, normalised to 1.73 m² of body surface area. Product literature, and many BNF entries, state renal thresholds as creatinine clearance. The BNF is explicit that the two are not interchangeable. For most drugs and most adults of average build, eGFR can be used to decide a dose; for some drugs and some patients, CrCl calculated with the Cockcroft–Gault formula is needed instead.
Decision workflow
- Open the drug’s Renal impairment heading. Note which measure its thresholds use: creatinine clearance (CrCl, mL/minute) or eGFR (mL/minute/1.73 m²).
- Should you calculate CrCl? Yes, with the Cockcroft–Gault formula, if any of these applies:
- a direct-acting oral anticoagulant (apixaban, dabigatran, edoxaban, rivaroxaban)
- a nephrotoxic drug (for example vancomycin, amphotericin B)
- a drug largely excreted by the kidneys with a narrow therapeutic index (for example digoxin, sotalol)
- the patient is 75 or older
- the patient is at an extreme of muscle mass (BMI below 18 or above 40 kg/m²)
YesCalculate CrCl and compare it with the CrCl bands.
NoeGFR is acceptable for most drugs in adults of average build and height.
- Match the number to the band the entry states. If dose adjustment by CrCl matters and the monograph gives no advice, the product literature (SPC) is the next source. If renal function is changing quickly, as in acute kidney injury, recalculate and review the dose.
Cockcroft–Gault creatinine clearance
CrCl (mL/minute) =(140 − age) × weight (kg) × constantserum creatinine (micromol/litre)
- Constant
- 1.23 for men, 1.04 for women
- Weight
- ideal body weight where fat is likely to be the major part of body mass; actual weight if it is less than ideal
- Ideal body weight
- 50 kg (men) or 45.5 kg (women) + 0.91 × (height in cm − 152.4)
| Drug | Measure | What it says |
|---|---|---|
| Apixaban | CrCl | Avoid if CrCl is below 15 mL/minute. In atrial fibrillation, reduce to 2.5 mg twice daily if CrCl is 15–29 mL/minute, regardless of age or weight. |
| Dabigatran etexilate | CrCl | Avoid if CrCl is below 30 mL/minute; dose reductions between 30 and 50 mL/minute depend on the indication. |
| Gabapentin | CrCl | Dose bands from 50–79 mL/minute down to 15–29 mL/minute. |
| Metformin hydrochloride | eGFR | Avoid in adults if eGFR is below 30 mL/minute/1.73 m²; reduce the dose in moderate impairment (see product literature). |
| Nitrofurantoin | eGFR | Avoid in adults if eGFR is below 45 mL/minute/1.73 m², with a narrow short-course exception between 30 and 44. |
The rule is not the same for every drug, and the BNF says so: it recommends calculating CrCl for toxic drugs, for elderly patients and for patients at extremes of muscle mass, and the MHRA adds DOACs and renally excreted drugs with a narrow therapeutic index. Where a monograph gives no renal advice and CrCl matters, consult the product literature.
Worked check: apixaban in atrial fibrillation
A 78-year-old man, 170 cm tall and weighing 62 kg, is starting apixaban for non-valvular atrial fibrillation. Serum creatinine is 170 micromol/litre; the laboratory reports an eGFR of 33 mL/minute/1.73 m². Calculate his creatinine clearance and find the dose.
Look it up: Apixaban (BNF, opens in a new tab)
Show the workingHide the answer
Answer. 2.5 mg twice daily.
- Weight. His ideal body weight is 50 + 0.91 × (170 − 152.4) = 66 kg. His actual weight, 62 kg, is lower, so actual weight is used.
- CrCl. (140 − 78) × 62 × 1.23 ÷ 170 = 27.8 mL/minute.
- Indications and dose. For atrial fibrillation the dose is 5 mg twice daily, reduced to 2.5 mg twice daily if at least two of: age 80 or over, weight 60 kg or less, serum creatinine 133 micromol/litre or more. He meets only one.
- Renal impairment. In atrial fibrillation, reduce to 2.5 mg twice daily if CrCl is 15–29 mL/minute, regardless of age or body-weight. At 27.8 he is in that band.
Read against his eGFR of 33, he would appear to sit outside the 15–29 band and receive 5 mg twice daily: exactly the overestimate the MHRA warns about for DOACs. Both headings had to be read; neither alone gives the dose.
Practise questions on kidney disease and renal dosing Questions from every section that turn on renal function
Interactions: reading one entry
Open either drug's interactions page (from the monograph's Interactions link, or Interactions A to Z) and find the other drug alphabetically. Each entry has the same parts:
Illustrative schematic, not the live BNF
- Metronidazolethe other drug, listed alphabetically on the warfarin page
- increases the anticoagulant effect of warfarinwhat happens
- monitor the INR and adjust the dosewhat to do
- Severity: SevereSevere, Moderate, Mild or Unknown; severe entries carry a red marker
- Evidence: StudyStudy, Anecdotal or Theoretical
Some pages open with a Food and lifestyle section before the drug list; warfarin's covers vitamin K, diet and alcohol. A chart with six drugs has fifteen possible pairs, which is too many to check one by one under time pressure. The vignette usually points at the suspect: the drug started this week, the new symptom, the rising creatinine. Check the pairs the story implicates first.
Side-effects: the frequency band matters
Side-effects are grouped as Common or very common, Uncommon, Rare or very rare, and Frequency not known, with class-wide effects under “For all…” and drug-specific ones under the drug's name. When a question asks which medicine caused a symptom, the useful signal is a common band plus a start date that fits.
Seven timed lookups
Each lookup names the drug, the indication and the patient, and has one checkable answer. Open the BNF link, start the timer if you want one, and find the answer before you reveal it. The answers were read on the live BNF in November 2026; the BNF is updated monthly, so if it now says something different, the live BNF is right.
Naproxen in acute gout
A 58-year-old man has acute gout in his right first metatarsophalangeal joint. He takes no other medicines and has no history of peptic ulceration or renal impairment. Find the BNF adult oral dose of naproxen for acute gout.
Look it up: Naproxen (BNF, opens in a new tab)
Show the answer and the routeHide the answer
Answer. 750 mg initially, then 250 mg every 8 hours until the attack has passed.
RouteNaproxen › Indications and dose › Acute gout › By mouth › Adult
Naproxen has several indications, and the others carry different regimens: the dose is only right under the matching indication. Contra-indications, Cautions and Renal impairment on the same page still apply before an NSAID is prescribed.
Simvastatin and clarithromycin
A 66-year-old woman takes simvastatin 40 mg at night. She now needs clarithromycin for a chest infection. Starting from the simvastatin monograph, find the BNF interaction entry for clarithromycin: what does it advise, and what severity does it carry?
Look it up: Simvastatin (BNF, opens in a new tab)
Show the answer and the routeHide the answer
Answer. Clarithromycin is predicted to increase exposure to simvastatin, and the manufacturer advises avoiding the combination. Severity: Severe. Evidence: Study.
RouteSimvastatin › Interactions (link) › the interactions page › Clarithromycin
“Avoid” leaves the prescriber two options: withhold the statin for the course, or choose a different antibacterial. Which is right depends on the patient and local guidance.
Propranolol in asthma
A 24-year-old woman with asthma, using a salbutamol inhaler and an inhaled corticosteroid, asks about propranolol for migraine prophylaxis. Find whether asthma appears under propranolol's Contra-indications or its Cautions, and how that line is labelled.
Show the answer and the routeHide the answer
Answer. Contra-indications. Asthma is listed in the text headed “For all beta-adrenoceptor blockers (systemic)”: it is a class contra-indication, not one specific to propranolol.
RoutePropranolol hydrochloride › Contra-indications › For all beta-adrenoceptor blockers (systemic)
A contra-indication outranks a caution. When a PSA item wants “stop this” or “avoid this option”, it is usually built on a contra-indication, so read that list first.
Amlodipine and ankle swelling
A 71-year-old man started amlodipine 5 mg once daily for hypertension six weeks ago and now has bilateral ankle swelling. In amlodipine's Side-effects, find peripheral oedema: which frequency band is it in?
Look it up: Amlodipine (BNF, opens in a new tab)
Show the answer and the routeHide the answer
Answer. Common or very common, in the class text “For all calcium-channel blockers”.
RouteAmlodipine › Side-effects › For all calcium-channel blockers › Common or very common
Almost any drug can cause almost anything. In an adverse-reaction item, look for the drug that lists the symptom in a common band and whose start date fits; that usually separates the culprit from the decoys. It does not replace examining him for other causes such as heart failure.
Lithium levels
A 45-year-old man with bipolar disorder started lithium carbonate a week ago. Find how long after a dose the serum-lithium sample should be taken, and how often levels are checked until they are stable.
Look it up: Lithium carbonate (BNF, opens in a new tab)
Show the answer and the routeHide the answer
Answer. 12 hours after the dose (with twice-daily dosing, the morning dose is withheld until the sample is taken). Levels are checked 1 week after starting and 1 week after every dose or formulation change, then weekly until stable.
RouteLithium carbonate › Monitoring requirements › For all lithium salts › Serum concentrations
The same entry gives the initial target for bipolar disorder in a lithium-naïve patient (0.6–0.8 mmol/litre), a lower start for people aged 65 or over, and the interval once stable: every 3 months for the first year, then every 6 months, or every 3 months for higher-risk groups.
Taking alendronic acid
A 69-year-old woman is starting alendronic acid 70 mg once weekly for postmenopausal osteoporosis. Find the BNF directions for how she should take it.
Look it up: Alendronic acid (BNF, opens in a new tab)
Show the answer and the routeHide the answer
Answer. Swallow the tablet whole with plenty of water, sitting or standing, on an empty stomach at least 30 minutes before breakfast or any other oral medicine, then stay sitting or standing upright for at least 30 minutes.
RouteAlendronic acid › Directions for administration (then Patient and carer advice)
Counselling answers in Communicating Information items usually come from Directions for administration and Patient and carer advice together.
Trimethoprim in pregnancy
A 29-year-old woman who is 9 weeks pregnant has symptoms of a lower urinary-tract infection. Find what trimethoprim's Pregnancy heading says.
Look it up: Trimethoprim (BNF, opens in a new tab)
Show the answer and the routeHide the answer
Answer. Teratogenic risk in the first trimester, because it is a folate antagonist; manufacturers advise avoiding it during pregnancy.
RouteTrimethoprim › Pregnancy
The heading tells you what to avoid. The choice of antibacterial for a urinary-tract infection in pregnancy comes from the treatment summary and current national and local guidance, and the general principles from Medicines guidance › Prescribing in pregnancy.
Five scenarios
Longer cases that need two steps or a calculation. Allow two minutes each, roughly the pace of a 4-mark Prescription Review item.
Low-severity community-acquired pneumonia
A 34-year-old man has community-acquired pneumonia, assessed as low severity (CRB65 score 0), and is being treated at home. He has no drug allergies and takes no other medicines. Name the BNF first-line antibacterial, then give the adult dose and course length.
Show the answer and the routeHide the answer
Answer. Amoxicillin 500 mg by mouth three times a day for 5 days. The monograph allows an increase to 1 g three times a day if necessary.
RouteTreatment summary › Pneumonia, community-acquired › Low severity › then Amoxicillin › Indications and dose › Community-acquired pneumonia › Adult
The summary names the drug but the monograph holds the dose. The same summary lists the alternatives in penicillin allergy (clarithromycin, doxycycline, or erythromycin in pregnancy). Local antimicrobial guidance may differ.
Methotrexate and trimethoprim
A 67-year-old woman takes methotrexate once weekly for rheumatoid arthritis. Her GP is considering trimethoprim for a lower urinary-tract infection. Find the BNF interaction entry: what is the risk, what does it advise, and how severe is it?
Show the answer and the routeHide the answer
Answer. Trimethoprim increases the risk of haematological side-effects (sometimes fatal) when given with methotrexate; the manufacturer advises avoid. Severity: Severe. Evidence: Anecdotal. A second line adds that both drugs can increase the risk of nephrotoxicity.
RouteMethotrexate › Interactions › Trimethoprim
Two drugs with the same type of toxicity get their own line (“Both … can increase the risk of”). Read the whole entry, not just the first sentence.
Morphine oral solution
A 74-year-old man receiving palliative care is prescribed morphine sulfate oral solution 5 mg every 4 hours when required for pain. The ward stocks morphine sulfate 10 mg/5 mL oral solution. Confirm in the BNF that this strength exists, then work out the volume of one 5 mg dose.
Show the answer and the routeHide the answer
Answer. 2.5 mL (5 mg ÷ 10 mg × 5 mL). Morphine sulfate 10 mg/5 mL oral solution is listed under Medicinal forms as a Schedule 5 controlled drug.
RouteMorphine › Medicinal forms › Oral solution
Morphine oral solutions come in more than one strength, and the monograph points prescribers to its Important safety information to make sure the correct preparation is prescribed. Prescribe the dose in milligrams; the volume is for the person giving it.
Ibuprofen while breastfeeding
A 31-year-old woman, 3 weeks after delivery and exclusively breastfeeding, has acute low back pain. She has no asthma, no renal impairment and no history of peptic ulceration. Find what the BNF says about ibuprofen in breast feeding.
Look it up: Ibuprofen (BNF, opens in a new tab)
Show the answer and the routeHide the answer
Answer. Specialist sources indicate it is suitable for use in breast-feeding; negligible amounts are present in milk.
RouteIbuprofen › Breast feeding
The heading answers the question about the infant. Her own contra-indications and cautions still apply, and Medicines guidance › Prescribing in breast-feeding sets out the general principles.
Nitrofurantoin and eGFR
A 46-year-old woman of average build (BMI 24 kg/m²) has an uncomplicated lower urinary-tract infection. She is not pregnant. Her eGFR is 52 mL/minute/1.73 m². Find nitrofurantoin's renal advice and decide whether her kidney function rules it out.
Look it up: Nitrofurantoin (BNF, opens in a new tab)
Show the answer and the routeHide the answer
Answer. It does not. The BNF advises avoiding nitrofurantoin in adults with an eGFR below 45 mL/minute/1.73 m², with a narrow exception between 30 and 44 (a 3 to 7 day course for a lower urinary-tract infection caused by suspected or proven multidrug-resistant bacteria, only if the benefit outweighs the risk). At 52 she is above the threshold.
RouteNitrofurantoin › Renal impairment
This entry is written in eGFR, and for a 46-year-old of average build eGFR is the right measure. Compare the apixaban example above, where it is not.
Practise Prescribing questions with the BNF open Write the prescription, then check it against the monograph
Navigation challenges
Five problems where the skill is choosing where to look. Pick the first place you would open; the explanation says why, and what you would find there.
A 48-year-old white British man has newly confirmed hypertension. He does not have diabetes. You need the first-line drug class. Where do you go first?
Show the explanationHide the answer
Treatment summary: Hypertension. A choice-of-drug question belongs to a treatment summary. Under Drugs for hypertension, step 1 for someone without type 2 diabetes, aged 55 or below and not of Black African or African-Caribbean origin, is an ACE inhibitor or an ARB. Only then open the chosen drug's monograph for its dose. Opening ramipril first assumes the answer. Hypertension treatment summary
A 72-year-old man taking warfarin for atrial fibrillation needs clarithromycin. Where do you find what to do about the combination?
Show the explanationHide the answer
The warfarin interactions page, entry for clarithromycin. The monograph's Interactions heading is only a link; the advice is on the interactions page, under the other drug's name. There, clarithromycin increases the anticoagulant effect of warfarin; the manufacturer advises monitoring the INR and adjusting the dose (Severity: Severe; Evidence: Anecdotal). Monitoring requirements describes warfarin monitoring in general, not what this pair needs. Warfarin interactions
A 70-year-old woman with a creatinine clearance of 40 mL/minute is to start gabapentin for neuropathic pain. Where is her reduced dose?
Show the explanationHide the answer
Gabapentin: Renal impairment, Dose adjustments. Drug-specific renal doses sit in the drug's own Renal impairment heading. Gabapentin's are stated in creatinine clearance bands: for 30–49 mL/minute, 300–900 mg daily in 3 divided doses. The Medicines guidance page explains which estimate of renal function to use, but gives no doses for individual drugs; Indications and dose gives the usual dose, which is the wrong one for her. Gabapentin
A 63-year-old man is starting amiodarone. Which tests are needed before treatment, and how often afterwards? Where do you look?
Show the explanationHide the answer
Amiodarone: Monitoring requirements. Monitoring requirements: liver function tests before treatment and then every 6 months; serum potassium before treatment; a chest x-ray before treatment; thyroid function tests before treatment and then every 6 months in adults. Side-effects lists what can go wrong, but not the testing schedule. Amiodarone hydrochloride
A 26-year-old woman with epilepsy is being considered for sodium valproate. Where are the regulator's pregnancy prevention requirements set out?
Show the explanationHide the answer
Sodium valproate: Important safety information, with Conception and contraception. Important safety information carries MHRA and CHM advice. For valproate it includes Valproate and reproductive risks: the conditions of the Pregnancy Prevention Programme for females of childbearing potential and the annual risk acknowledgement form. Conception and contraception gives the contraception requirements. This advice has been revised more than once, so read the current entry rather than relying on memory. Sodium valproate
Practise Prescription Review Charts to check for interactions, contra-indications and dosing errors
Where each exam section's answers usually are
A starting point, not a rule: any section can need any heading. Each section name opens its page in the PSA guide.
| PSA section | Where its answers usually are |
|---|---|
| Prescribing | Treatment summaries for the choice; Indications and dose under the matching indication; Renal and Hepatic impairment; Contra-indications |
| Prescription Review | Interactions; Contra-indications and Cautions; Renal impairment; Indications and dose to check what was written |
| Planning Management | Treatment summaries; Medicines guidance for the general principle |
| Communicating Information | Directions for administration; Patient and carer advice; Important safety information; Pregnancy and Breast feeding |
| Calculation Skills | Indications and dose for mg/kg doses and maximums; Medicinal forms for strengths; the renal guidance for Cockcroft–Gault |
| Adverse Drug Reactions | Side-effects by frequency band; Interactions; Important safety information |
| Drug Monitoring | Monitoring requirements and Pre-treatment screening; Indications and dose where it gives the timing of levels |
| Data Interpretation | Monitoring requirements; Renal impairment; thresholds and targets in the treatment summary |
On the day
- Pace by marks: 120 minutes for 200 marks is 36 seconds a mark, so a 10-mark prescribing item has earned about six minutes and a 2-mark item about a minute.
- If a lookup is not converging after a minute or so, flag the question and move on.
- Do the lookup even when you are fairly sure; confirming a dose or an interaction takes seconds.
- Read the patient's details again before you choose a band: age, weight, renal function, pregnancy, the other drugs on the chart.
- Write doses with units, and write micrograms in full.
This page prints as a handout, with every answer shown.